Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521607 · ClinicalTrials.gov registry record · NA
Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)
A NA study of Neonatal Jaundice, sponsored by Picterus AS.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05521607: Recruiting NA study of Neonatal Jaundice, sponsored by Picterus AS.
NCT05521607 is a NA study of Neonatal Jaundice that is actively recruiting participants, run by Picterus AS. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521607, a NA study of Neonatal Jaundice, is actively recruiting participants, sponsored by Picterus AS.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
Primary Outcome
Evaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.
Conditions Studied
Interventions
- DEVICE Picterus Jaundice Pro (JP)
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2025-06-15 |
| Phase | NA |
What NCT05521607 shows while recruiting
NCT05521607 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Neonatal Jaundice appearing as the primary indexed condition, and to 1 intervention - of which Picterus Jaundice Pro (JP) is the first listed.
NCT05521607 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05521607 about?
NCT05521607 is a clinical study titled "Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)". A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.
What is the current status of trial NCT05521607?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-01-06. Estimated completion is 2025-06-15.
What conditions does trial NCT05521607 study?
This clinical trial studies the following conditions: Neonatal Jaundice.
What interventions are being tested in trial NCT05521607?
The interventions under investigation include: Picterus Jaundice Pro (JP) (DEVICE).
Who is sponsoring clinical trial NCT05521607?
This trial is sponsored by Picterus AS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521607 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Jaundice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05521607's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI